Trial intelligence / Profile preview

Oral versus sublingual midazolam premedication in children with congenital heart disease before anesthesia

ISRCTN33764131Phase 4Completed

Sponsor
Onassis Cardiac Surgery Center
Start
Jul 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of midazolam in Cardiovascular Malformation (CVM) (2 arms), sponsored by Onassis Cardiac Surgery Center. Started Jul 2021; status: completed.

02

Drugs

midazolam
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on ISRCTN33764131.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN33764131.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call